Candriam SCA’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-44,489
| Closed | -$444K | – | 856 |
|
|
2023
Q1 | $444K | Sell |
44,489
-38,713
| -47% | -$387K | ﹤0.01% | 792 |
|
|
2022
Q4 | $933K | Sell |
83,202
-19,626
| -19% | -$220K | 0.01% | 709 |
|
|
2022
Q3 | $1.04M | Buy |
+102,828
| New | +$1.04M | 0.01% | 697 |
|
|
2021
Q3 | – | Sell |
-475,696
| Closed | -$6.91M | – | 908 |
|
|
2021
Q2 | $6.91M | Buy |
+475,696
| New | +$6.91M | 0.05% | 342 |
|
|
2020
Q2 | – | Sell |
-277,700
| Closed | -$7.03M | – | 865 |
|
|
2020
Q1 | $7.03M | Hold |
277,700
| – | – | 0.08% | 278 |
|
|
2019
Q4 | $7.19M | Sell |
277,700
-2,000
| -0.7% | -$51.8K | 0.08% | 283 |
|
|
2019
Q3 | $5.45M | Hold |
279,700
| – | – | 0.07% | 299 |
|
|
2019
Q2 | $4.55M | Hold |
279,700
| – | – | 0.06% | 351 |
|
|
2019
Q1 | $6.34M | Hold |
279,700
| – | – | 0.08% | 271 |
|
|
2018
Q4 | $7.16M | Buy |
279,700
+25,000
| +10% | +$640K | 0.11% | 217 |
|
|
2018
Q3 | $8.32M | Buy |
+254,700
| New | +$8.32M | 0.11% | 219 |
|
|
2017
Q4 | – | Sell |
-20,000
| Closed | -$685K | – | 776 |
|
|
2017
Q3 | $685K | Sell |
20,000
-10,000
| -33% | -$343K | 0.01% | 624 |
|
|
2017
Q2 | $1.2M | Sell |
30,000
-40,000
| -57% | -$1.59M | 0.02% | 553 |
|
|
2017
Q1 | $2.58M | Sell |
70,000
-5,000
| -7% | -$184K | 0.05% | 391 |
|
|
2016
Q4 | $2.39M | Buy |
+75,000
| New | +$2.39M | 0.05% | 334 |
|